Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression
Abstract Objective Amyotrophic lateral sclerosis (ALS) is a heterogeneous disease with a complex etiology that lacks biomarkers predicting disease progression. The objective of this study was to use longitudinal cerebrospinal fluid (CSF) samples to identify biomarkers that distinguish fast progressi...
Main Authors: | Lucas Vu, Krystine Garcia‐Mansfield, Antonio Pompeiano, Jiyan An, Victoria David‐Dirgo, Ritin Sharma, Vinisha Venugopal, Harkeerat Halait, Guido Marcucci, Ya‐Huei Kuo, Lisa Uechi, Russell C. Rockne, Patrick Pirrotte, Robert Bowser |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-11-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.51890 |
Similar Items
-
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia
by: Lisa Uechi, et al.
Published: (2024-03-01) -
UFLC-derived CSF extracellular vesicle origin and proteome
by: Thompson, A, et al.
Published: (2018) -
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
by: Delvenne, A, et al.
Published: (2024) -
Individualized CSF proteomics for real-time glioma espionage
by: C. Riviere-Cazaux, et al.
Published: (2022-01-01) -
CSF proteomic signature predicts progression to Alzheimer's disease dementia
by: Eleonora M. Vromen, et al.
Published: (2022-01-01)